TheEdgeResearch
Home / Stocks / HBOSF

EastWest Bioscience Inc. (HBOSF)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$7,780
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.71
52-Wk Range
1.0E-4-0.0635
CEO
Rodney Gelineau
Country
CA
Currency
USD

EastWest Bioscience Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $7,780. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -256.2%. Its beta of 0.71 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.02
Price / Book
-0.03
EV / EBITDA
-0.83
Gross margin
4.5%
Operating margin
-354.0%
Net margin
-256.2%
Return on equity
Debt / equity
-5.56
Current ratio
0.40
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2023-08-25
Headquarters
Vancouver, BC, CA
About EastWest Bioscience Inc.

EastWest Bioscience Inc. is a holistic health enterprise that vertically integrates its operations, focusing on the production and sale of hemp-based nutritional goods throughout Canada and the United States. Beyond its core offerings, the company manages Sangster's Health Center retail locations, which distribute supplements and other wellness items via a network of franchises and its e-commerce site. Additionally, it participates in the property management sector. Established in 2016, EastWest Bioscience Inc. maintains its primary offices in Penticton, Canada.

Comparable companies

EastWest Bioscience Inc. is most often compared with the following Healthcare names:

ABMCACCACRXMEQURFPSUFGLSHQGNBTMOSTQNMDBFNNMX
More research on HBOSF
HBOSF technical analysis HBOSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →